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Objective: Based on Pittsburg Sleep Quality Index, it has been 
reported that most human immunodeficiency virus (HIV) positive 
patients suffer from various degrees of sleep problems. Sleep 
disorders can affect quality of life, physical and social functioning and 
can also cause chronic fatigue. Some psychological and physiological 
factors are related to sleep quality. The purpose of the present study 
was to evaluate sleep quality and its related psychological and 
physiological factors in Iranian human immunodeficiency virus positive 
patients who were candidates for initiation of antiretroviral therapy . 
Method: This was a cross- sectional study of 59 HIV positive out-
patients in stages 2 or 3 of HIV disease who were candidates for 
initiation of antiretroviral therapy. Pittsburg Sleep Quality Index (PSQI), 
Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating 
Scale (HARS) and Somatization Subscale of Symptom Checklist 90 
(SCL-90) were used to assess the patients’ sleep quality, depression, 
anxiety and physiological factors, respectively. SPSS software version 
12 was used for data analysis. The Pearson correlation coefficient was 
utilized to analyze the correlation between PSQI and other quantitative 
variables. 
Results: Based on the sleep quality assessment, 47.5 % of the 
patients had PSQI > 5 that was defined as sleep disturbances. A 
significant correlation was found between sleep quality and HDRS (r = 
0.531, p = 0.0001), HARS (r = 0.627, p = 0.0001) and somatization 
subscale of SCL-90 (r = 0.36, p = 0.05). 
Conclusion: This study showed that human immunodeficiency virus 
positive individuals suffer from sleep disorders at least as same as the 
general population, and that psychological variables including 
depression and anxiety and physiological variables including physical 
morbidities in different systems of the body lead to sleep disturbance in 
this population. 
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Sleep disorders are common problems and have been 
reported in 10% to 40% of the general population (1). 
These problems can affect quality of life, physical and 
social functioning and can also cause chronic fatigue 
(1). It seems that HIV (human immunodeficiency 
virus) infected individuals are more vulnerable to sleep 
disturbances (2). Based on Pittsburg Sleep Quality 
Index, it has been reported that 73 % to 100% of HIV 
positive patients suffer from various degrees of sleep 
problems (3-4). Normal sleep architecture can be 
changed (1-2), and slow wave sleep may be increased 
significantly in HIV positive individuals (5-7). Greater 
sleep onset latency, early morning awakening, more  
frequent awakenings during the night, and reduced 
sleep efficiency have been reported in this population  
(8-11). Anxiety and depression are psychological 
factors that affect sleep quality (1, 12-13). Sleep  
disturbance is a common symptom of depression (13). 
Patients with anxiety disorders have delayed sleep  
 
 
 
onset and reduced total sleep time (12). HIV positive 
patients with higher levels of depression or anxiety  
showed more sleep disturbances than HIV positive 
individuals without depression and anxiety symptoms 
(8). Physical symptoms such as pain, abdominal 
cramping, diarrhea, incontinence, itching, burning, 
fever, night sweats, cough and dyspnea can also cause 
sleep disturbances in HIV positive patients (8). Some 
studies have suggested an inverse correlation between 
immune system and sleep quality in HIV positive 
patients (14-15), but others did not show this 
relationship (5, 16-17). The frequency of sleep 
disturbances was evaluated in different populations 
such as general population (35.2%) (18), renal 
transplant (62%) (19), dialysis (73.8%) (20), multiple 
sclerosis (87.2%) (21) and cancer patients (71.7%) 
(18). Sleep quality and its correlated factors have not 
been evaluated in the Iranian HIV positive individuals. 
The aim of this study was to evaluate the sleep quality 
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and its related psychological and physiological factors 
in the Iranian HIV positive patients who were 
candidates for initiation of antiretroviral therapy.  
 
Material and Methods 
 
This cross-sectional study was conducted in the HIV 
Clinic of Imam Khomeini Hospital Complex in Tehran, 
Iran during a one year period. Fifty nine (42 males and 
17 females), 18 to 55 year old HIV positive patients 
were included in this survey. The stages of HIV 
infection were determined according to 1993 revised 
classification of centers for disease control and 
prevention (CDC) definition. The stages A, B and C 
are based on patients’ clinical condition related to HIV 
infection. The stages 1, 2 and 3 are based on patients’ 
CD4 cells count. The CD4 cell counts for stages 2 and 
3 are 200/µl to 499/µl and below 200/µl, respectively 
(22). All the participants had CD4 cell counts of less 
than 350/µl and were candidates for initiation of 
antiretroviral therapy. The patients’ demographic and 
laboratory data were collected. Pittsburg Sleep Quality 
Index (PSQI), the validated Persian versions of 
Hamilton Depression Rating Scale (HDRS), Hamilton 
Anxiety Rating Scale (HARS) (23) and Somatization 
Subscale of Symptom Checklist 90 (SCL-90) (24, 25) 
were used to assess the patients’ sleep quality, 
depression, anxiety and physiological factors, 
respectively. It should be explained that PSQI is a self 
measured, 7-component questionnaire including 
subjective sleep quality, sleep latency, sleep duration, 
habitual sleep efficiency, sleep disturbances, use of 
sleeping medications and daytime dysfunction during 
the last month. The validated Persian version of PSQI 
(Cronbach's alpha= 0.77) was utilized in the present 
study (26); PSQI of greater than 5 was considered as 
sleep disturbance (11). An expert interviewer 
completed the HDRS and HARS questionnaires. The 
HDRS is a 17-item scale, and it is categorized from 0 
to 4 (27). The HARS evaluates 14 anxiety related 
parameters, with scores of 0 to 4 (28). Somatization 
dimension of SCL-90 represents physical morbidity. 
This self- reported questionnaire includes 12 items. 
This subscale represents distress in different systems of 
the body such as cardiovascular, gastrointestinal, 
respiratory, autonomic systems and is rated from 0 
(none) to 4 (extreme) (29).  SPSS software version 12 
was used for data analysis.  Normal distribution of the 
variables was assessed according to Kolmograph-
Smirnov test.  The Pearson correlation coefficient was 
used to analyze the correlation between PSQI and other 
quantitative variables. The patients were assigned into 
two groups: patients with normal sleep and patients 
with sleep disturbance (PSQI score > 5). The Chi-
square test was used to determine the relationship 
between these two groups and the stages of HIV  
 
 
 
 infection. P value of less than 0.05 was considered as 
statistically significant.  
 
Result 
 
Fifty nine HIV positive patients (42 males and 17 
females) with the mean ± SD age of 36.9 ± 9.8 were 
included in the study. The patients’ demographic data 
were summarized in Table 1. In this study, 42.4% of 
the patients had a high-school diploma, 55.9% were 
married and 52.5% were self-employed. The most 
common routes of HIV transmission were sexual 
contacts (35.6 %) and injection drug use (33.9 %). Oral 
candidiasis (10.2 %) and chronic hepatitis C (23.7%) 
were the most common opportunistic infection and 
concomitant disease in the patients . 
The patients’ mean ± SD of PSQI, HDRS, HARS and 
Somatization Subscale of SCL-90 scores were 5.88 ± 
4.22, 12.58 ± 7.18, 8.58 ± 5.78 and 11.29 ± 7.45, 
respectively. The classification of these scores is 
demonstrated in Table 2. 
 Based on the sleep quality assessment, 47.5 % of the 
patients had PSQI > 5 that was defined as sleep 
disturbances. A significant correlation was found 
between sleep quality and HDRS (r = 0.531, p = 
0.0001), HARS (r = 0.627, p= 0.0001) and 
Somatization Subscale of SCL-90 (r = 0.36, p = 0.05) 
(Table 3). The frequency of PSQI > 5 of the patients in 
different stages of HIV infection are displayed in Table 
4. The correlation between the patients’ HIV infection 
stages and PSQI scores was significant ,  (Χ2 (1) = 
5.732, p = 0.017). There was not any significant 
correlation between the patients’ laboratory data and 
their sleep quality except neutrophil percentage (r = 0. 
309, p = 0.023). 
 
Discussion 
 
Although sleep disorders are common problems in the 
general population, the prevalence of sleep disorders is 
more common in the HIV positive population than the 
general population, and it can affect the quality of life 
of these patients (1). The correlation between the 
severity of HIV infection and its progression to 
advanced stages of this disease has been reported in 
several studies (8, 14-15). We detected sleep 
disturbances in 47.5 % of the Iranian HIV positive 
individuals who were candidates for antiretroviral 
therapy. Sleep disorders have been reported in 63% to 
100% of other HIV positive populations (2, 8, 11). 
Wibbeler et al.  Reported that 63.9 % of the HIV 
positive patients could be classified as poor sleepers 
based on the PSQI score (11). In another study, 
Robbins et al. found that all their HIV infected 
participants suffered from sleep disturbance (8). 
In our patients, the prevalence of sleep disorders was 
similar to 10% to 40% of the Iranian general 
population and to other countries (2, 19, 30). 
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Table1: Demographic data of the patients 
Characteristics Frequency (percent) or Mean± SD 
Sex  Male  
Female 
42 (71.2 %) 
17 (28.8 %) 
Age 36.9 ± 9.8 
Weight 65.9 ± 12.7 
Period between diagnosis and treatment 19.14 ± 25.23 
CD4 count 157.91 ±117.23 
Education  Illiterate 
Elementary 
Guidance school 
High school 
More than Diploma 
4 (6.8 %) 
9 (15.3 %) 
13 (22.0 %) 
25 (42.4 %) 
8 (13.6%) 
Transmission  IV drug injection 
Sex 
Needle 
IV drug injection and sex 
Unknown 
Blood 
20 (33.9 %) 
21 (35.6 %) 
1 (1.7 %) 
11 (18.6 %) 
4 (6.8 %) 
2 (3.4 %) 
Job Self-employed 
House-hold 
Employee 
Student 
Taxi driver 
Unemployed 
Engineer 
Medical staff 
31 (52.5 %) 
9 (15.3 %) 
4 (6.8 %) 
3 (5.1 %) 
4 (6.8 %) 
6 (10.2 %) 
1 (1.7 %) 
1 (1.7 %) 
Opportunistic Infection TB 
CMV 
Candidiasis 
None 
Zoster 
TB and Candidiasis 
1 (1.7 %) 
2 (3.4 %) 
6 (10.2 %) 
47 (79.7 %) 
2 (3.4 %) 
1 (1.7 %) 
Concomitant disease  Diabetes 
Depression 
HBV 
HCV 
GI disease 
None 
HBV and HCV 
1 (1.7 %) 
1 (1.7 %) 
2 (3.4 %) 
11 (18.6 %) 
3 (5.1 %) 
38 (64.4 %) 
3 (5.1 %) 
State of marriage  Single 
Married  
Divorced 
19 (32.2 %) 
33 (55.9 %) 
7 (11.9 %) 
The patients’ demographic data including age, sex, duration of HIV infection, CD4 count, HIV transmission rout , education, job and 
baseline diseases and concomitant infections.  
IV: Intravenous, TB: Tuberculosis, CMV: Cytomegalovirus, HCV: Hepatitis C virus, HBV: Hepatitis B virus, GI: Gastrointestinal, SD: 
Standard deviation 
 
Table2: Classification of the patients’ depression, anxiety and sleep quality status 
Parameter Score Frequency (%) Mean± SD 
Depression  Normal  (0-7) 
Mild Depression (8-13) 
Moderate Depression (14-18) 
Severe Depression (19-22) 
Very Severe Depression (≥ 23) 
12 (20.3 %) 
22 (37.3 %) 
11 (18.6 %) 
8 (13.6 %) 
6 (10.2 %) 
12.58 +/- 7.18 
Anxiety 
 
Normal (0-13) 
Mild Anxiety (14-17) 
Moderate Anxiety (18-24) 
Severe Anxiety (25-30) 
46 (78 %) 
11 (18.6 %) 
1 (1.7 %) 
1 (1.7 %) 
8.58 +/- 5.78 
Sleep quality Patient with normal sleep 
Patient with sleep disturbance 
31 (52.5 %) 
28 (47.5 %) 
5.88 +/- 4.22 
The patients’ depression, anxiety and sleep quality were assessed and categorized based on the Hamilton Depression Rating Scale 
(HDRS), Hamilton Anxiety Rating Scale (HARS) and  
Pittsburg Sleep Quality Index (PSQI) respectively 
 
 
Table3: Correlation between sleep quality and neuropsychiatric scales 
Scales  Correlation coefficient p value 
HDRS 0.531 0.0001 
HARS 0.627 0.0001 
Somatization subscale of SCL90 0.36 0.05 
HDRS: Hamilton Depression Rating Scale, HARS: Hamilton Anxiety Rating Scale, SCL90: Symptom Checklist 90 
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Table 4: Data of stages of HIV infection and patients with and without sleep disturbance 
Stage of HIV infection 
Patients with normal sleep, 
frequency (%) 
Patients with disturbed 
sleep, frequency (%) 
P value 
2 
3 
16 (27.1 %) 
31 (25.4 %) 
6 (10.2 %) 
22 (37.3 %) 
0.017 
A 
B 
C 
25 (42.4 %) 
4 (6.8 %) 
2 (3.4 %) 
22 (37.2 %) 
4 (6.8 %) 
2 (3.4 %) 
0.981 
Stage of HIV infection was determined according to 1993 revised classification of centers for disease control and prevention 
 (CDC)  definition. The Chi-square test was used to determine the relationship between these two groups and stages of HIV infection 
 
Sleep disorders were reported in 32.1 % of the Austrian 
general population (31).  In a random sample study of 
an Iranian urban population, sleep disturbances were 
detected in 37% of the participants (30).  Nearly equal 
prevalence of sleep disturbances in our HIV positive 
individuals and the general population may be 
attributed to our inclusion criteria of the study. We 
evaluated HIV positive out-patients with CD4 count of 
lower than 350/µl. These patients did not receive 
antiretroviral therapy and did not complain about 
serious concomitant diseases or opportunistic 
infections. Predisposing factors for sleep disturbances 
in this population have been reported as antiretroviral, 
complications of concomitant diseases and 
opportunistic infections including general pain, 
abdominal cramping, diarrhea, incontinence, itching, 
burning, fever, night sweats, cough and dyspnea (8).   
In white et al. study, no difference was observed 
between HIV positive patients with CD4 counts of less 
than 400 and seronegative controls in sleep disturbance 
frequency (7) . 
A significant correlation was found between the stages 
of HIV infection and sleep disturbances in the present 
study.  In previous studies, it was reported that the 
quality of sleep will be worsen along with disease 
progression in HIV positive individuals (8, 14-15). 
Darko et al. reported that sleep disturbances was 
related to CDC stages of HIV infection (15). The risk 
of opportunistic infections and an indication for 
antibiotic prophylaxis will increase with HIV infection 
progression in this population. Opportunistic infections 
can produce various symptoms including pain, fever, 
night sweet, pain, cough and dyspnea that can disturb 
patients’ sleep (8) . 
Our findings showed that both psychological and 
physiological factors can affect sleep quality. We 
found a direct correlation between sleep disturbance 
and depression, anxiety and physical morbidity as 
measured by HDRS, HARS and Somatization Subscale 
of SCL- 90. These findings are in line with the results 
of other studies (2, 8, 11). Depression is the most 
important factor that affects sleep quality (11); 
physiological factors such as pain and psychological 
factors such as psychological stressors in HIV positive  
patients can also affect their sleep quality (1). We used 
the HDRS and HARS to assess depression and anxiety, 
and we found they are correlated with sleep quality (8).  
Depression and anxiety are frequent depression and 
anxiety status in our patients. These questionnaires  
have been used to evaluate these mental disorders in  
HIV positive patients in another study (16). HIV 
positive individuals with anxiety have problems in 
falling asleep, decreased slow wave sleep and more 
non REM sleep (2, 8). In this study, physical morbidity 
in HIV infected patients was assessed based on 
Somatization Subscale of SCL- 90. This questionnaire 
has been used in HIV positive population in another 
study in Iran (24). Physical morbidities including pain, 
abdominal cramping, diarrhea, incontinence, itching, 
burning, fever, night sweats, cough and dyspnea are 
common problems in HIV infected patients. These 
morbidities can cause problems in falling asleep and 
may diminish sleep efficiency (8). Also, pain may 
cause non-restorative sleep in HIV positive individuals 
(1).  
 
Limitations 
The limitations of this study were the small sample size 
and the absence of control group. Sleep disturbances 
and predisposing factors should be evaluated in a 
prospective and well controlled study with sufficient  
sample size . 
We suggest that treatment of depression, anxiety and 
physical morbidity can improve sleep quality in HIV 
positive patients. 
 
Conclusion 
This study showed that human immunodeficiency virus 
positive individuals suffer from sleep disorders at least 
as same as the general population, and that 
psychological variables including depression and 
anxiety and physiological variables including physical 
morbidities in different systems of the body lead to 
sleep disturbance in this population. 
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